2nd Quarter - Report
CROSSROADS STRATEGIES, LLC for INTELLIA THERAPEUTICS
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education and advocacy related to gene therapy. Education around COVID-19 therapies. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. FY 2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1425, State Health Care Premium Reduction Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK New | Military Legislative Assistant, Sen. Patty Murray; Legislative Assistant, Rep. Adam Smith |
| MATHEW LAPINSKI | — |
| MARC NUMEDAHL | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.